High-Throughput Screen in Cryptococcus neoformans Identifies a Novel Molecular Scaffold That Inhibits Cell Wall Integrity Pathway Signaling

ACS Infectious Diseases
Kate HartlandDamian J Krysan

Abstract

Cryptococcus neoformans is one of the most important human fungal pathogens; however, no new therapies have been developed in over 50 years. Fungicidal activity is crucially important for an effective anticryptococal agent and, therefore, we screened 361,675 molecules against C. neoformans using an adenylate kinase release assay that specifically detects fungicidal activity. A set of secondary assays narrowed the set of hits to molecules that interfere with fungal cell wall integrity and identified three benzothioureas with low in vitro mammalian toxicity and good in vitro anticryptococcal (minimum inhibitory concentration = 4 μg/mL). This scaffold inhibits signaling through the cell wall integrity MAP kinase cascade. Structure-activity studies indicate that the thiocarbonyl moiety is crucial for activity. Genetic and biochemical data suggest that benzothioureas inhibit signaling upstream of the kinase cascade. Thus, the benzothioureas appear to be a promising new scaffold for further exploration in the search for new anticryptococcal agents.

References

Sep 8, 1997·The Journal of Cell Biology·J Philips, I Herskowitz
May 29, 1999·Antimicrobial Agents and Chemotherapy·R K Li, M G Rinaldi
Nov 2, 2002·Molecular Microbiology·Un Sung JungDavid E Levin
Sep 25, 2004·Antimicrobial Agents and Chemotherapy·Sarit MarkovichNir Osherov
Feb 25, 2005·Molecular Biology of the Cell·Yong-Sun BahnJoseph Heitman
Jun 28, 2005·Antimicrobial Agents and Chemotherapy·Marybeth A Maligie, Claude P Selitrennikoff
Jul 16, 2008·Journal of Biomolecular Screening·Damian J Krysan, Louis Didone
Jul 10, 2009·Current Opinion in Infectious Diseases·Derek J SloanDavid G Lalloo
Jul 21, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Tihana BicanicThomas S Harrison
Jun 12, 2010·Nature Protocols·Louis DiDoneDamian J Krysan
May 15, 2012·Science·Gordon D BrownStuart M Levitz
Sep 13, 2012·PLoS Pathogens·Arielle Butts, Damian J Krysan
Apr 5, 2013·The New England Journal of Medicine·Jeremy N DayJeremy J Farrar
Apr 5, 2013·The New England Journal of Medicine·John R Perfect
Jul 31, 2013·Journal of Biomolecular Screening·Jennifer L A RabjohnsPeter R Williamson
May 3, 2014·Cold Spring Harbor Perspectives in Medicine·Terry Roemer, Damian J Krysan
Jul 6, 2014·Cold Spring Harbor Perspectives in Medicine·Kyung J Kwon-ChungYong-Sun Bahn
Nov 25, 2014·Cell·Jessica C S BrownHiten D Madhani

❮ Previous
Next ❯

Citations

Oct 22, 2016·MedChemComm·Huy X NgoKeith D Green
Aug 4, 2016·Future Medicinal Chemistry·Damian J Krysan
Feb 9, 2017·Antimicrobial Agents and Chemotherapy·Maureen J DonlinRyan P Murelli
Oct 2, 2016·Journal of Fungi·Kaila M Pianalto, J Andrew Alspaugh
Jun 9, 2016·Virulence·Michaela SpitzerGerard D Wright
Feb 10, 2021·Nature Reviews. Microbiology·Kali R IyerLeah E Cowen

❮ Previous
Next ❯